Company / Current Assets per Share
Traws Pharma, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.19
FY2024
5-year range
$0.18 / $4.77
FY2020-FY2024
Trend
+101.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2024 after 2 years of decline, reaching $2.19.
Based on SEC 10-K filings.
2.19 in FY2024 with a 5-year CAGR of -12.0%.
Improved from $1.88 to $2.19 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -22.9%
- 5-Year CAGR
- -12.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current assets per share increased 101.8% year-over-year.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.19 | +101.8% |
| FY2023 | $1.08 | -42.5% |
| FY2022 | $1.88 | -60.6% |
| FY2021 | $4.77 | +2582.3% |
| FY2020 | $0.18 | -95.7% |
| FY2019 | $4.14 | -83.3% |
| FY2018 | $24.74 | +3310.9% |
| FY2017 | $0.73 | -92.0% |
| FY2016 | $9.06 | +748.0% |
| FY2015 | $1.07 | -51.1% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026